Perspectives for BIA after ECO2026
The 33rd European Congress of Obesity (ECO2026), held in Istanbul from 12–15 May 2026, offered a comprehensive view of the current state and future directions of the obesity field. The obesity field is at a pivotal moment, shaped by three converging forces: the pharmacological revolution driven by GLP-1/GIP receptor agonists, the push to reframe obesity […]
Bioimpedance in bariatric surgery
GLP-1 Analogues: Mechanisms, Clinical Implications, and the Role of Body Composition Monitoring
GLP-1 analogues are drugs mimicking a gut hormone that stimulates insulin, inhibits
glucagon, slows gastric emptying and increases satiety. They improve glycemic control and reduce body mass (5.8-17.3%), but 25-39% of the loss is fat-free mass, hence the importance of body composition monitoring.
The Role of Bioimpedance Spectroscopy in the Obese Patient’s Treatment Adherence
Bioimpedance spectroscopy (BIS) goes beyond BMI limits by measuring FMI, FFMI, phase
angle, capacitance and impedance ratio. It finely characterizes body composition, detects sarcopenic obesity and guides treatment adherence in the obese patient with a more precise and motivating approach.
Cumulative oxidative and inflammatory responses to repeated depth training in breath-hold divers: a multiparametric field study
Leveque, Clement, Frédéric Lemaître, Juan Valdivia-Valdivia, et al. « Cumulative Oxidative and Inflammatory Responses to Repeated Depth Training in Breath-Hold Divers: A Multiparametric Field Study ». European Journal of Applied Physiology, publication en ligne anticipée, 12 novembre 2025.
Reproducibility of Bioimpedance Spectroscopy Parameters to Evaluate Skeletal Muscle Properties
Freitas, Silvère De, Alain Letourneur, Jérémie Bouvier, Alexandre Fouré, et Etienne Gouraud. Journal of Electromyography and Kinesiology 86 (février 2026): 103107.